Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Celltech presents novel receptor tyrosine kinase inhibitors for cancer, psoriasis, etc.

Dec. 4, 2002

Phase I data demonstrate promising efficacy and safety for oral Raf kinase inhibitor

Dec. 3, 2002

Radiosensitizing effects of karenitecin in human glioma cells

Dec. 3, 2002

Evidence that trimidox sensitizes malignant glioma cells to ionizing radiation

Dec. 3, 2002

Inhibitors of tubulin polymerization prepared and tested at Aventis

Dec. 3, 2002

DN-101 evaluated in androgen-independent prostate cancer

Dec. 2, 2002

Data support use of TLK-286 in combination chemotherapy

Dec. 2, 2002

Simultaneous inhibition of angiogenesis and tumor growth with human MAb targeting integrins

Dec. 2, 2002

Aclacinomycin analogues produced by Finnish scientists using combinatorial biosynthesis

Dec. 2, 2002

SAR on a novel series of pyrrolobenzodiazepine antitumor agents

Dec. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....